Cargando...

Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients

Bisphosphonates are well known inhibitors of osteoclast activity and thus may be employed to influence osteoblast activity. The present study was designed to evaluate the in vivo effects of zoledronic acid (ZA) on the proliferation and osteoblastic commitment of mesenchymal stem cells (MSC) in osteo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Luca Dalle Carbonare, Monica Mottes, Giovanni Malerba, Antonio Mori, Martina Zaninotto, Mario Plebani, Alessandra Dellantonio, Maria Teresa Valenti
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2017-06-01
Series:International Journal of Molecular Sciences
Assuntos:
Acceso en liña:http://www.mdpi.com/1422-0067/18/6/1261
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!